164 related articles for article (PubMed ID: 29048676)
21. Silencing of augmenter of liver regeneration inhibited cell proliferation and triggered apoptosis in U266 human multiple myeloma cells.
Zeng HQ; Luo Y; Lou SF; Liu Q; Zhang L; Deng JC
Braz J Med Biol Res; 2017 Aug; 50(10):e6139. PubMed ID: 28876364
[TBL] [Abstract][Full Text] [Related]
22. Autophagy in anti-apoptotic effect of augmenter of liver regeneration in HepG2 cells.
Shi HB; Sun HQ; Shi HL; Ren F; Chen Y; Chen DX; Lou JL; Duan ZP
World J Gastroenterol; 2015 May; 21(17):5250-8. PubMed ID: 25954098
[TBL] [Abstract][Full Text] [Related]
23. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
Yang T; Yao S; Zhang X; Guo Y
Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
[TBL] [Abstract][Full Text] [Related]
24. High-mobility group protein B1 silencing promotes susceptibility of retinoblastoma cells to chemotherapeutic drugs through downregulating nuclear factor-κB.
Chai Y; Xiao J; Zhang S; Du Y; Luo Z; Zhou X; Huang K
Int J Mol Med; 2018 Mar; 41(3):1651-1658. PubMed ID: 29328447
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
Wang HY; Zhang Y; Zhou Y; Lu YY; Wang WF; Xin M; Guo XL
Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556
[TBL] [Abstract][Full Text] [Related]
26. Augmenter of liver regeneration (ALR) exhibits a dual signaling impact on hepatic acute-phase response.
Dayoub R; Buerger L; Ibrahim S; Melter M; Weiss TS
Exp Mol Pathol; 2017 Jun; 102(3):428-433. PubMed ID: 28506765
[TBL] [Abstract][Full Text] [Related]
27. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
Lei J; Li Q; Gao Y; Zhao L; Liu Y
Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
[TBL] [Abstract][Full Text] [Related]
28. [Small interfering RNA-mediated COX-2 gene silencing enhances chemosensitivity of KB/VCR cells by suppressing MDR-1 gene expression and P-glycoprotein activity].
Mo X; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):718-22. PubMed ID: 24849444
[TBL] [Abstract][Full Text] [Related]
29. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
[TBL] [Abstract][Full Text] [Related]
31. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
32. Synergistic Effect of TPD7 and Berberine against Leukemia Jurkat Cell Growth through Regulating Ephrin-B2 Signaling.
Ma W; Zhu M; Yang L; Yang T; Zhang Y
Phytother Res; 2017 Sep; 31(9):1392-1399. PubMed ID: 28703366
[TBL] [Abstract][Full Text] [Related]
33. shRNA-mediated EMMPRIN silencing inhibits human leukemic monocyte lymphoma U937 cell proliferation and increases chemosensitivity to adriamycin.
Gao H; Jiang Q; Han Y; Peng J; Wang C
Cell Biochem Biophys; 2015 Mar; 71(2):827-35. PubMed ID: 25260396
[TBL] [Abstract][Full Text] [Related]
34. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
Zhang X; Huang H; Xu Z; Zhan R
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
[TBL] [Abstract][Full Text] [Related]
35. Augmenter of liver regeneration: Essential for growth and beyond.
Ibrahim S; Weiss TS
Cytokine Growth Factor Rev; 2019 Feb; 45():65-80. PubMed ID: 30579845
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line.
Najjary S; Mohammadzadeh R; Mansoori B; Vahidian F; Mohammadi A; Doustvandi MA; Khaze V; Hajiasgharzadeh K; Baradaran B
Med Oncol; 2021 Oct; 38(12):142. PubMed ID: 34655330
[TBL] [Abstract][Full Text] [Related]
37. Viscum articulatum Burm. f. aqueous extract exerts antiproliferative effect and induces cell cycle arrest and apoptosis in leukemia cells.
Mishra R; Sharma S; Sharma RS; Singh S; Sardesai MM; Sharma S; Mishra V
J Ethnopharmacol; 2018 Jun; 219():91-102. PubMed ID: 29555410
[TBL] [Abstract][Full Text] [Related]
38. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
Xiao R; Gan M; Jiang T
Hum Exp Toxicol; 2017 Nov; 36(11):1169-1176. PubMed ID: 27941168
[TBL] [Abstract][Full Text] [Related]
39. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia.
Pereira JK; Machado-Neto JA; Lopes MR; Morini BC; Traina F; Costa FF; Saad ST; Favaro P
Eur J Cancer; 2015 Sep; 51(14):2076-85. PubMed ID: 26238016
[TBL] [Abstract][Full Text] [Related]
40. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
